JTO Clin Res Rep. 2021 Apr 9;2(5):100169. doi: 10.1016/j.jtocrr.2021.100169. eCollection 2021 May.
PMID:34590020
Type 2 inflammation drives an airway basal stem cell program through insulin receptor substrate signaling.
Wang X, Hallen NR, Lee M, Samuchiwal S, Ye Q, Buchheit KM, Maxfield AZ, Roditi RE, Bergmark RW, Bhattacharyya N, Ryan T, Gakpo D, Raychaudhuri S, Dwyer D, Laidlaw TM, Boyce JA, Gutierrez-Arcelus M, Barrett NA.